<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180728040618N12</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-09-04</date_registration>
      <primary_sponsor></primary_sponsor>
      <public_title>Effect of dry needling and muscle energy technique on hamstring tightness in athletes</public_title>
      <acronym></acronym>
      <scientific_title>The effect of adding dry needling to muscle energy technique on flexibility and physical performance in athletes with hamstring tightness: a randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/92927</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants were randomly allocated into two groups (Intervention and Control) with a 1:1 ratio using a computer-generated randomization list (block randomization with variable block sizes). Allocation concealment was maintained using sealed envelopes, Blinding description: This study is double-blinded (participants and outcome assessor). To blind the participants, sham dry needling is used in the control group. To blind the outcome assessor, group allocations are kept hidden from the assessor.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Hamstring muscle tightness.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants receive active dry needling applied to active trigger points of the hamstring muscle in 3 sessions (every other day), followed immediately by muscle energy technique (MET) for hamstring stretching. Intervention 2: Control group: Participants receive sham dry needling (using non-penetrating sham needles over the hamstring muscle area) in 3 sessions (every other day), followed immediately by the identical muscle energy technique (MET) protocol as the intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
De-identified individual participant data, study protocol, and outcome measurements including AKE ROM, stretch tolerance, and leg hop test results.

When:
Starting 6 months after publication of the main results in a peer-reviewed journal

To whom:
Academic and clinical researchers in the field of physiotherapy and sports rehabilitation.

Conditions:
For systematic reviews, meta-analyses, and secondary analytical studies upon approval of a formal proposal.

Where to obtain:
Dr. Holakoo Mohsenifar (Email: mohsenifar.h@iums.ac.ir)

How to obtain:
Applicants must send a formal request email to the principal investigator along with a brief research proposal. The request will be evaluated by the study investigators within a maximum of 14 business days.

Comments:
Data will be made available solely for non-commercial academic research after signing a data sharing agreement.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Holakoo Mohsenifar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 23, Shah Nazari St, Madar Sq, Mirdamad Blvd, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1540913711</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>mohsenifar.h@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Holakoo Mohsenifar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 23, Shah Nazari St, Madar Sq, Mirdamad Blvd, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1540913711</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>mohsenifar.h@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Recreational athletes aged 18 to 35 years
Presence of hamstring tightness defined as an Active Knee Extension (AKE) deficit of 20 degrees or greater
Signing written informed consent to participate in the study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of lower extremity surgery, orthopedic injuries, or neurological disorders
History of low back pain within the past year
History of prior dry needling or acupuncture
Needle phobia
Coagulation disorders or use of anticoagulant medications
Contraindications to dry needling (e.g., diabetes, vascular diseases, epilepsy, active skin lesions/infections at the treatment site, allergy, psychiatric disorders)
Concurrent hamstring stretching exercises or participation in other physical therapy or exercise programs during the study period</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M62.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Contracture of muscle</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants receive active dry needling applied to active trigger points of the hamstring muscle in 3 sessions (every other day), followed immediately by muscle energy technique (MET) for hamstring stretching.</i_keyword>
      <i_keyword>Control group: Participants receive sham dry needling (using non-penetrating sham needles over the hamstring muscle area) in 3 sessions (every other day), followed immediately by the identical muscle energy technique (MET) protocol as the intervention group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Active knee extension range of motion (hamstring flexibility). Timepoint: Before intervention and immediately after intervention. Method of measurement: Goniometer during Active Knee Extension (AKE) test.</prim_outcome>
      <prim_outcome>Hamstring stretch tolerance. Timepoint: Before intervention and immediately after intervention. Method of measurement: Visual Analogue Scale (VAS) during Active Knee Extension test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Single leg hop distance. Timepoint: Before intervention and immediately after intervention. Method of measurement: Measuring tape in centimeters.</sec_outcome>
      <sec_outcome>Triple hop distance. Timepoint: Before intervention and immediately after intervention. Method of measurement: Measuring tape in centimeters.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name>Iran University of Medical Sciences</sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name></source_name>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-08-31</approval_date>
        <contact_name>Ethics Committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
